Christie Hospital NHS Foundation Trust-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

    The British journal of surgery, Vol. 110, Núm. 9, pp. 1161-1170

  4. The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

    HPB, Vol. 25, Núm. 9, pp. 985-999

2022

  1. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry

    Cancers, Vol. 14, Núm. 10

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

    Nature Reviews Gastroenterology and Hepatology, Vol. 17, Núm. 9, pp. 557-588

  2. Systematic review of educational interventions to improve contouring in radiotherapy

    Radiotherapy and Oncology, Vol. 144, pp. 86-92

2019

  1. Clinical presentation, diagnosis and staging of cholangiocarcinoma

    Liver International, Vol. 39, Núm. S1, pp. 98-107

2017

  1. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Oncology, Vol. 18, Núm. 12, pp. 1688-1700

2012

  1. Implications of a positive sentinel node in oral squamous cell carcinoma

    Head and Neck, Vol. 34, Núm. 11, pp. 1580-1585

2010

  1. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a european multicenter trial

    Annals of Surgical Oncology, Vol. 17, Núm. 9, pp. 2459-2464

2006

  1. Erlotinib for frontline treatment of advanced non-small cell lung cancer: A phase II study

    Clinical Cancer Research, Vol. 12, Núm. 20 PART 1, pp. 6049-6055